Efficacy and Safety Evaluation Study of Implants With Periodontal Ligament

December 11, 2025 updated by: OrganTech, Inc.

Evaluation of the Efficacy and Safety of Periodontal Ligament Integrated Implants Via Residual Periodontal Ligament Tissue in Extraction Sockets

The goal of this clinical trial is to evaluate the efficacy and safety of periodontal ligament-integrated implants placed via residual periodontal ligament tissue in extraction sockets in adult patients (aged 18 and older) requiring extraction of a single-rooted tooth.

The main questions it aims to answer are:

  • Does the periodontal ligament-integrated implant achieve stable integration with the jawbone at 24 weeks after placement?
  • Can this implant reproduce physiological tooth mobility and sensory function similar to natural teeth while maintaining periodontal health?

This is a multicenter, single-arm, exploratory study with approximately six participants.

Participants will:

  • Undergo tooth extraction of one single-rooted tooth that meets eligibility criteria.
  • Receive immediate placement of a periodontal ligament-integrated implant into the extraction socket.
  • Attend scheduled follow-up visits over 48 weeks for assessments including:

    • Dental X-rays and clinical examinations to evaluate bone healing, periodontal ligament formation, and implant stability.
    • Measurements of tooth mobility, pocket depth, and pain levels.
    • Quality of life assessments using a standardized oral health questionnaire.

Researchers will monitor participants for implant integration, safety outcomes, and physiological function restoration over the study period.

Study Overview

Detailed Description

This multicenter, single-arm exploratory clinical trial investigates the efficacy and safety of periodontal ligament (PDL)-integrated implants placed immediately after tooth extraction, using residual periodontal ligament tissue within the extraction socket to achieve functional attachment. The investigational device is an unapproved medical implant designed to reproduce physiological tooth function by utilizing the periodontal tissue for anchorage and sensory integration, unlike conventional osseointegrated implants that rely solely on bone integration.

The rationale for this study is that preserving and integrating residual PDL tissue may allow the implant to develop a PDL-like attachment, potentially restoring physiological tooth mobility, mechanosensory feedback, and natural load distribution to the alveolar bone. This could enable improved long-term function and compatibility with adjacent natural teeth, particularly in cases where the implant is connected to them.

Participants will undergo immediate implant placement following extraction of a single-rooted tooth (incisor to premolar) that meets inclusion criteria. The implant-abutment assembly is secured temporarily using a fixation device to ensure stability during early healing. The fixation is maintained for approximately 9 weeks, followed by staged removal and functional loading through placement of a superstructure. Throughout the observation period (up to 48 weeks), multiple evaluations will be conducted to assess integration into the jawbone, periodontal attachment formation, bone remodeling, implant mobility, and patient-reported comfort.

Comprehensive radiographic, clinical, and physiological assessments will be performed to monitor healing dynamics, bone response, and periodontal adaptation. Safety will be assessed by recording adverse events related to surgery, device performance, or oral function. Oral hygiene and supportive care will be provided throughout the study.

The findings from this exploratory research are expected to provide foundational data regarding the biological feasibility, mechanical behavior, and clinical safety of PDL-integrated implants as a novel approach for immediate implant placement and restoration of physiological dental function.

Study Type

Interventional

Enrollment (Estimated)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Fukushima
      • Kōriyama, Fukushima, Japan
        • Recruiting
        • Minami Tohoku Medical Clinic
        • Contact:
        • Principal Investigator:
          • Shohei Kasugai
    • Tokyo
      • Minato-Ku, Tokyo, Japan
        • Recruiting
        • Hillside Akasaka Dental Clinic
        • Contact:
        • Principal Investigator:
          • Takamasa Miyahara

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients who have only one single-rooted tooth, from the upper or lower incisors to the premolars, which require extraction due to caries or a fracture, and who have healthy periodontal tissue remaining around the root of the tooth to be extracted.
  • The teeth adjacent to the tooth to be extracted are natural teeth with healthy periodontal tissues, and no abnormalities are found in dental X-rays, CT scans, periodontal pocket examinations, or physiological mobility tests. Also, patients should be able to achieve proper occlusion with opposing teeth.
  • Patients aged 18 years or older at the time of consent.
  • Patients who have provided written consent to participate in this clinical study and are able to comply with study visits and procedures.

Exclusion Criteria:

  • Patients whose jawbone is still growing.
  • Patients undergoing orthodontic treatment or wearing retainers after orthodontic treatment.
  • Patients with multiple missing teeth or an edentulous jaw where multiple occlusal support areas of the remaining teeth are missing.
  • Patients who have periodontal pockets of 4mm or more around the root of the tooth to be extracted or the teeth adjacent to the tooth to be extracted.
  • Patients with bacterial infection or acute inflammation such as periodontitis in the tooth to be extracted.
  • Patients with apical periodontitis in the tooth to be extracted.
  • Patients who will have two or more consecutive missing teeth or free-end edentulous space due to the extraction of the target teeth.
  • Patients who have already had the target tooth extracted.
  • Patients for whom extraction of the target tooth is expected to be difficult.
  • Patients who are not healthy enough to undergo the tooth extractions and surgical procedures required for implant treatment using this product.
  • Patients with abnormal root morphology or position (curved, tilted, etc.) of the tooth to be extracted.
  • Patients in whom this product cannot be implanted due to the root size of the tooth to be extracted (root length less than 10 mm, root diameter at the cervical part less than 5.4 mm in long diameter, less than 3.4 mm in short diameter) or malocclusion.
  • Patients with open bite.
  • Patients with a history of hypersensitivity to the components of this product or similar products.
  • Patients with alveolar bone resorption in the area where the implant is to be placed.
  • Patients with bleeding disorders. (There is a risk of abnormal bleeding and poor healing of the surgical site).
  • Patients with uncontrolled diabetes. (There is a risk of poor healing of the surgical site and increased susceptibility to infection.)
  • Patients for whom general oral surgery is contraindicated. (There is a risk that the invasive procedure may worsen the disease, cause recurrence of preexisting conditions, or result in poor healing of the surgical site postoperatively.)
  • Patients who undergo radiation therapy or chemotherapy due to malignant tumors, etc. (There is a risk that the surgical site may not heal properly.)
  • Patients receiving bisphosphonate therapy.
  • Patients who currently smoke.
  • Patients who do not understand or cooperate with the treatment.
  • Pregnant patients or patients who may be pregnant.
  • Any other patient deemed unsuitable for participation in this study by the principal investigator (or co-investigator).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Periodontal Ligament-Integrated Implant Placement
Participants undergo preoperative evaluation, including oral examination, CT imaging, and impressions for implant simulation and fabrication. After eligibility confirmation, a single-rooted tooth is extracted using minimally invasive techniques to preserve residual periodontal ligament tissue. A periodontal ligament-integrated implant with an abutment and fixation is immediately placed into the extraction socket and stabilized with dental cement. Sutures are removed after three weeks. The implant remains unloaded for about nine weeks for healing and integration into the jawbone, with periodic radiographic evaluation. A superstructure is then fabricated and placed for controlled occlusal loading. Once integration into the jawbone via regenerated periodontal ligament is confirmed, the fixation is removed and the implant functions independently. Oral care is maintained throughout the study.
The investigational device is a periodontal ligament-integrated implant designed for immediate placement into a tooth extraction socket. Unlike conventional osseointegrated implants, this device utilizes residual periodontal ligament tissue to establish functional attachment and physiological integration with the alveolar bone. The implant-abutment assembly is stabilized with a temporary fixation device for approximately nine weeks, during which integration into the jawbone through the residual periodontal ligament is promoted. After the healing phase, a definitive superstructure is fabricated and placed to allow controlled occlusal loading. Once integration into the jawbone and implant stability are confirmed, the fixation device is removed, and the implant functions independently. The device remains unapproved and is evaluated for safety and efficacy in this study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of integration into the jawbone at 24 Weeks Post-Implantation
Time Frame: 24 weeks after implantation
Presence or absence of integration with the jawbone at 24 weeks postoperatively (Rate of integration into the jawbone).
24 weeks after implantation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of integration into the jawbone Over Time
Time Frame: 9, 18, and 48 weeks postoperatively
Presence or absence of integration into the jawbone (9 weeks postoperatively, 18 weeks postoperatively, 48 weeks postoperatively).
9, 18, and 48 weeks postoperatively
Periodontal Pocket Depth
Time Frame: Baseline (approximately 11 weeks preoperative) to 48 weeks postoperatively
Periodontal pocket depth (mm) at Baseline (Visit 1 - approximatelly 11 weeks preoperative), and at 9, 18, 24, and 48 weeks postoperatively.
Baseline (approximately 11 weeks preoperative) to 48 weeks postoperatively
Physiological Instability (PT value) With Fixation
Time Frame: Immediately after surgery to 36 weeks postoperatively
Physiological instability (periotest value) immediately after surgery, 1 week after surgery, 3 weeks after surgery, 7 weeks after surgery, 9 weeks after surgery, 10 weeks after surgery, 14 weeks after surgery, 18 weeks after surgery, 24 weeks after surgery, and 36 weeks after surgery with fixation.
Immediately after surgery to 36 weeks postoperatively
Physiological Tooth Mobility (PT Value) Without Fixation
Time Frame: Baseline (approximately 11 weeks preoperative) to 48 weeks postoperatively
Physiological tooth mobility (periotest value) without fixation, measured at Baseline (approximately 11 weeks preoperatively) (Visit 3), and at 9, 18, 24, 36, and 48 weeks postoperatively, as well as clinical tooth mobility (Miller classification) assessed by the surgeon.
Baseline (approximately 11 weeks preoperative) to 48 weeks postoperatively
Perceptual and Sensory Evaluation (Pain)
Time Frame: Baseline (approximately 11 weeks preoperatively) to 48 weeks postoperatively
Perceptual and sensory evaluation (pain) using the numerical rating scale, conducted at Baseline (approximately 11 weeks preoperatively) (Visit 3), the day after surgery, and at 1, 3, 7, 9, 10, 14, 18, 24, 36, and 48 weeks postoperatively.
Baseline (approximately 11 weeks preoperatively) to 48 weeks postoperatively
Peri-Implant Bone Augmentation and Vertical Bone Resorption
Time Frame: Baseline (approximately 11 weeks preoperatively) to 48 weeks postoperatively
Peri-implant bone augmentation (formation) and vertical bone resorption (dental X-ray) assessed at Baseline (approximately 11 weeks preoperatively) (Visit 1), immediately after surgery, and at 3, 7, 9, 14, 18, 24, and 48 weeks postoperatively.
Baseline (approximately 11 weeks preoperatively) to 48 weeks postoperatively
Formation of Periodontal Ligament Space
Time Frame: 7 to 48 weeks postoperatively
Formation of the periodontal ligament space around the implant (dental X-ray), assessed at 7, 9, 14, 18, 24, and 48 weeks postoperatively.
7 to 48 weeks postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral Related QOL (Japan Prosthodontic Society Questionnaire)
Time Frame: Baseline (approximately 11 weeks preoperatively) to 48 weeks postoperatively
Oral related QOL (Japan Prosthodontic Society questionnaire), assessed at Baseline (approximately 11 weeks preoperatively) (Visit 3), and at 18 and 48 weeks postoperatively.
Baseline (approximately 11 weeks preoperatively) to 48 weeks postoperatively
Safety Evaluation - Incidence of adverse events and device-related defects
Time Frame: From implantation to 48 weeks postoperatively
Incidence of diseases and frequency of defects.
From implantation to 48 weeks postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Shohei Kasugai, PhD, Minami Tohoku Medical Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

December 11, 2025

First Submitted That Met QC Criteria

December 11, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 11, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Periodontal Ligament-Integrated Implant

Subscribe